Dr. Zheng has been engaged in hematology since 1998. She is good at standardized diagnosis and treatment of hematological malignancies, acute or chronic graft-versus-host disease follow-up, and monitoring of immune reconstruction after hematopoietic stem cell transplantation (HCT). She also focuses on cellular immunotherapy for relapsed or refractory (R/R) acute leukemia and micro-transplantation for R/R leukemia bridging to HCT. From 2008 to 2009, she spent two years studying in the City of Hope National Medical Center in Los Angeles U.S.A, where she was engaged in gene therapy and induced pluripotent stem cell research. In recent years, she has presided 4 projects of the National Natural Science Foundation of China (NSFC) and the Department of Science and Technology of Zhejiang Province, and published more than 10 articles included in SCI. As a main participant, she has won the National Science and Technology Progress Award and the provincial and ministerial level Science and Technology Progress Award several times. Undertake the diagnosis and treatment of rare disease "Gaucher disease" and chronic disease management of "Gaucher disease" in Zhejiang Province.

Hematological malignancies

Chemotherapy and cellular immunotherapy of leukemia and lymphoma

Chronic graft versus host disease

Gaucher disease

Member of hematology branch of zhejiang immunology society

Vice chairman of rare diseases branch of zhejiang medical association